Signal transduction in transgenic mouse models of human breast cancer - Implications for human breast cancer

被引：34
作者：
Marcotte, Richard [1 ,2 ]
Muller, William J. [1 ,2 ,3 ]
机构：
[1] Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Dept Biochem, Montreal, PQ, Canada
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
来源：
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA | 2008年 / 13卷 / 03期
关键词：
ErbB2; PyV MT; transgenic; MMTV; breast cancer;
D O I：
10.1007/s10911-008-9087-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The advent of genetically engineered mouse models (GEMs) of human breast cancer, have provided important insight into molecular basis or human breast cancer. This review will focus on two of the most extensively studied mouse models for human breast cancer involving mammary gland specific expression of the polyoma middle T (PyV MT) antigen and of the ErbB2. In addition, this review will discuss past and recent advances in understanding relative contribution of the signaling pathways in tumor induction and metastasis by these potent mammary oncogenes.
引用
收藏
页码：323 / 335
页数：13
相关论文
共 125 条
[1]   Stimulation of β1-integrin function by epidermal growth factor and heregulin-β has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase [J].
Adelsman, MA ;
McCarthy, JB ;
Shimizu, Y .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (09) :2861-2878
[2]   Models, mechanisms and clinical evidence for cancer dormancy [J].
Aguirre-Ghiso, Julio A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :834-846
[3]   SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation [J].
Ahuja, D ;
Sáenz-Robles, MT ;
Pipas, JM .
ONCOGENE, 2005, 24 (52) :7729-7745
[4]  
Allan Alison L, 2006, Breast Dis, V26, P87
[5]   Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice [J].
Almholt, K ;
Lund, LR ;
Rygaard, J ;
Nielsen, BS ;
Dano, K ;
Romer, J ;
Johnsen, M .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (04) :525-532
[6]   Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis [J].
Andrechek, ER ;
Hardy, WR ;
Siegel, PM ;
Rudnicki, MA ;
Cardiff, RD ;
Muller, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3444-3449
[7]  
Andrechek ER, 2003, CANCER RES, V63, P4920
[8]   Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma [J].
Bekri, S ;
Adélaïde, J ;
Merscher, S ;
Grosgeorge, J ;
Caroli-Bosc, F ;
Perucca-Lostanlen, D ;
Kelley, PM ;
Pébusque, MJ ;
Theillet, C ;
Birnbaum, D ;
Gaudray, P .
CYTOGENETICS AND CELL GENETICS, 1997, 79 (1-2) :125-131
[9]   A role for the scaffolding adapter GAB2 in breast cancer [J].
Bentires-Alj, M ;
Gil, SG ;
Chan, R ;
Wang, ZGC ;
Wang, YP ;
Imanaka, N ;
Harris, LN ;
Richardson, A ;
Neel, BG ;
Gu, HH .
NATURE MEDICINE, 2006, 12 (01) :114-121
[10]   CDK inhibitors: Cell cycle regulators and beyond [J].
Besson, Arnaud ;
Dowdy, Steven F. ;
Roberts, James M. .
DEVELOPMENTAL CELL, 2008, 14 (02) :159-169
12345678910